CPC Launches Aseptic Product for Cell and Gene Therapy Cryopreservation
DOWNERS GROVE, Ill., Sept. 11, 2024 /PRNewswire/ -- CPC (Colder Products Company), part of Dover (NYSE: DOV) and a leading manufacturer...
DOWNERS GROVE, Ill., Sept. 11, 2024 /PRNewswire/ -- CPC (Colder Products Company), part of Dover (NYSE: DOV) and a leading manufacturer...
WOKING, England, Sept. 11, 2024 /PRNewswire/ -- IDBS, a provider of cloud software for BioPharma companies, is thrilled to announce...
New RFID-powered solution helps Oracle Cloud SCM customers ensure the right supplies are available at the right time and the...
HYDERABAD, India, Sept. 11, 2024 /PRNewswire/ -- PharmaScroll, a renowned pharma market research and business analytics company, proudly announces the successful conclusion...
SCOTTSDALE, Ariz., Sept. 11, 2024 /PRNewswire/ -- CustomerInsights.AI has once again been recognized in the Gartner Hype Cycle for Life...
Pharma company's patent-pending novel AI technology designed for small and sparse datasets typical of most real-world scenarios shows dramatically lower...
Advances in mathematical models can illustrate the benefits of microgravity on drug performance and patient experience on Earth. EL SEGUNDO,...
'ixEngage' simplifies and accelerates the connection to care SAN FRANCISCO, Sept. 11, 2024 /PRNewswire/ -- ixlayer, a healthcare technology platform...
BOULDER, CO / ACCESSWIRE / September 11, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing...
MIAMI, FL / ACCESSWIRE / September 11, 2024 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a preclinical-stage pharmaceutical company focused on developing...
LAVAL, QC / ACCESSWIRE / September 11, 2024 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC)...
MIAMI, FL, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on...
Boston (September 11, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to...
NEW YORK, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company dedicated to improving the...
Elraglusib is a Class-Leading GSK-3β Inhibitor with a Novel, Multimodal Mechanism of Action in Multiple Refractory Cancer TrialsOrphan Drug Designation...
To date, SciSparc has advanced $4.25 million to Automax under the Bridge Loan agreement and amendments thereto TEL AVIV, Israel,...
Shifting Operational Strategy in Colombia and Ramping Up Other Initiatives in Order to Accelerate the Timeline to More Significant Revenue...
New patent is a major advancement in the capabilities of speech analysis and has the potential to revolutionize various industries...
BOSTON, Sept. 10, 2024 /PRNewswire/ -- AG Mednet, the pioneering force in clinical trial process management, continues to experience rapid...
Expanding Impact to Connect Healthcare Companies and Their Most Important Audiences PHILADELPHIA, Sept. 10, 2024 /PRNewswire/ -- Health Union, the...